StoneCalibre's EdgeBio Acquires Transgenomic's IC Business
September 10, 2015
StoneCalibre affiliate Edge BioSystems has acquired the Ion Chromatography business from Transgenomic (NASDAQ: TBIO). The business, which will be renamed Concise Separations, is responsible for researching, developing, manufacturing and marketing bulk resins and high performance liquid chromatography columns with applications across fields such as pharma, foods, life sciences and forensics. Concise Separations will operate as a division within EdgeBio, which was acquired by StoneCalibre in July 2014.